Fredun Pharmaceuticals Ltd.
Fundamentals
- Market cap
- ₹1,314 cr
- P/E
- 40.29×
- ROE
- 13.96%
- Debt / equity
- 1.18
- Div yield
- 0.03%
- 52-week range
- 690.00 — 2620.00
The timeline — 2 notes on Fredun Pharmaceuticals Ltd.
May 2026
- 25 May 26 · 10:07 PM IST Brief Brief · Earnings · Small cap
Fredun Pharmaceuticals posts 60% profit jump and declares 2:1 bonus
Annual revenue climbed 40% to ₹633.3 crore as the board approved a five-fold expansion of authorised capital to support the bonus issue.
- 25 May 26 · 9:54 PM IST Brief Brief · Earnings · Small cap
Fredun Pharmaceuticals lifts profit 60% and declares 2:1 bonus
Annual profit hit ₹33.2 crore on a 40% revenue jump to ₹633 crore. The board also hiked authorised capital five-fold to ₹50 crore.